OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools
Lily Arrué, Alexandra Cigna-Méndez, Tábata Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1914-1914
Open Access | Times Cited: 11
Lily Arrué, Alexandra Cigna-Méndez, Tábata Barbosa, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1914-1914
Open Access | Times Cited: 11
Showing 11 citing articles:
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Francesco Bruno, Paolo Abondio, Rossella Bruno, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102068-102068
Open Access | Times Cited: 35
Francesco Bruno, Paolo Abondio, Rossella Bruno, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102068-102068
Open Access | Times Cited: 35
Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 741-741
Open Access | Times Cited: 4
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 741-741
Open Access | Times Cited: 4
Multi-targeted benzylpiperidine–isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Closed Access
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Closed Access
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Vinita Sharma, Prabodh Chander Sharma, Jurnal Reang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107378-107378
Closed Access | Times Cited: 3
Vinita Sharma, Prabodh Chander Sharma, Jurnal Reang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107378-107378
Closed Access | Times Cited: 3
Novel Thiosemicarbazone Quantum Dots in the Treatment of Alzheimer’s Disease Combining In Silico Models Using Fingerprints and Physicochemical Descriptors
Nguyen Minh Quang, Trần Thái Hòa, Hoa Le Thi, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11076-11099
Open Access | Times Cited: 5
Nguyen Minh Quang, Trần Thái Hòa, Hoa Le Thi, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 11076-11099
Open Access | Times Cited: 5
Synergistic Approaches in Neurodegenerative Therapeutics: Multi-Target Drug Innovative Interventions for Alzheimer’s Disease
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
(2024)
Open Access | Times Cited: 1
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
(2024)
Open Access | Times Cited: 1
Resistance Exercise Training as a New Trend in Alzheimer’s Disease Research: From Molecular Mechanisms to Prevention
Alexis Sepúlveda-Lara, Paulina Sepúlveda, Gabriel Nasri Marzuca-Nassr
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7084-7084
Open Access | Times Cited: 1
Alexis Sepúlveda-Lara, Paulina Sepúlveda, Gabriel Nasri Marzuca-Nassr
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7084-7084
Open Access | Times Cited: 1
Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies
Smita Jain, R. P. Singh, Tripti Paliwal, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173943-173943
Closed Access | Times Cited: 1
Smita Jain, R. P. Singh, Tripti Paliwal, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 247, pp. 173943-173943
Closed Access | Times Cited: 1
AlzyFinder: A Machine-Learning-Driven Platform for Ligand-Based Virtual Screening and Network Pharmacology
Jessica Valero-Rojas, Camilo Andrés Ramírez-Sánchez, Laura Pacheco-Paternina, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access
Jessica Valero-Rojas, Camilo Andrés Ramírez-Sánchez, Laura Pacheco-Paternina, et al.
Journal of Chemical Information and Modeling (2024)
Closed Access
Computational studies for pre-evaluation of pharmacological profile of gut microbiota-produced gliclazide metabolites
Maja Đanić, Nebojša Pavlović, Dragana Zaklan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Maja Đanić, Nebojša Pavlović, Dragana Zaklan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Innovating Drug Design for Alzheimer’s Disease via Reinforcement Learning for Enhanced Molecular Generation
Nishank Satish, Manikanta Bukapindi, K Shreyas, et al.
Lecture notes in networks and systems (2024), pp. 255-269
Closed Access
Nishank Satish, Manikanta Bukapindi, K Shreyas, et al.
Lecture notes in networks and systems (2024), pp. 255-269
Closed Access
